Name: Commercialisation strategy (VRCI)
Uploaded: 2022-06-15T07:11:32.374722+00:00
Duration: 1881 s
Channel: Vox Markets
Description: Commercialisation strategy (VRCI)

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/937/003937/video_uLqn1NG.mp4#t=1376

Vox Markets

Commercialisation strategy (VRCI)

Key benefits of the Tuteva test (VRCI)

Size of the addressable market (VRCI)

Superior clinical performance of Tuteva vs existing diagnostics (VRCI)

Positive response from last week's America Transplant Congress (VRCI)

Update on Clarava & Protega (VRCI)

Clinical importance of #VRCI's suite of tests (VRCI)

Future newsflow (VRCI)

The ‘golden rule’ when investing healthcare, is to buy ‘best in class’ technology targeted at large addressable markets. Here Sara Barrington CEO of Verici DX explains why this pioneering immunodiagnostics firm - developing a full suite of next generation pre/post kidney transplant tests - ticks the box. 

Key benefits of the Tuteva test (VRCI) Start 
Size of the addressable market (VRCI) 06:12.10 
Superior clinical performance of Tuteva vs existing diagnostics (VRCI) 07:11.15 
Positive response from last week's America Transplant Congress (VRCI) 13:01.20 
Update on Clarava & Protega (VRCI) 16:46.20 
Clinical importance of #VRCI's suite of tests (VRCI) 20:35.03 
Commercialisation strategy (VRCI) 22:56.03 
Future newsflow (VRCI) 27:13.05

The ‘golden rule’ when investing healthcare, is to buy ‘best in class’ technology targeted at large addressable markets. Here Sara Barrington CEO of Verici DX explains why this pioneering immunodiagnostics firm - developing a full suite of next generation pre/post kidney transplant tests - ticks the box. Key benefits of the Tuteva test (VRCI) Start Size of the addressable market (VRCI) 06:12.10 Superior clinical performance of Tuteva vs existing diagnostics (VRCI) 07:11.15 Positive response from last week's America Transplant Congress (VRCI) 13:01.20 Update on Clarava &amp; Protega (VRCI) 16:46.20 Clinical importance of #VRCI's suite of tests (VRCI) 20:35.03 Commercialisation strategy (VRCI) 22:56.03 Future newsflow (VRCI) 27:13.05

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/937/003937/video_uLqn1NG.mp4